Comparison of macular function and visual fields after membrane blue or infracyanine green staining in vitreoretinal surgery

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 3, 2010, Pages 381-388

  Schmid Kubista, Katharina E ^a   Lamar, Peggy D ^a   Schenk, Alexandra ^a   Stolba, Ulrike ^a   Binder, Susanne ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

Epiretinal membrane; Infracyanine green; Macular hole; Membrane blue; Visual field; Vitreoretinal surgery

Indexed keywords

DYE; INFRACYANINE GREEN; MEMBRANE BLUE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CATARACT EXTRACTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIRETINAL MEMBRANE; EYE SURGERY; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PSEUDOPHAKIA; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; RETINA MACULA HOLE; RETINA TEAR; SCLERA BUCKLING PROCEDURE; VISUAL ACUITY; VISUAL FIELD; VITREORETINAL SURGERY;

AGED; AGED, 80 AND OVER; BASEMENT MEMBRANE; COLORING AGENTS; EPIRETINAL MEMBRANE; FEMALE; HUMANS; INDOCYANINE GREEN; MACULA LUTEA; MALE; MIDDLE AGED; PERIMETRY; PROSPECTIVE STUDIES; RETINAL PERFORATIONS; STAINING AND LABELING; TOMOGRAPHY, OPTICAL COHERENCE; TRYPAN BLUE; VISUAL ACUITY; VISUAL FIELDS; VITRECTOMY;

EID: 77949271495     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1213-4     Document Type: Article

References (44)

1. JD Gass 1988 Idiopathic senile macular hole. Its early stages and pathogenesis Arch Ophthalmol 106 629 639 3358729 1:STN:280:DyaL1c7pt1CrtQ%3D%3D
2. P Mitchell W Smith T Chey JJ Wang A Chang 1997 Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia Ophthalmology 104 1033 1040 9186446 1:STN:280:DyaK2szivF2rtQ%3D%3D (Pubitemid 27255417)
3. L Kodjikian T Richter M Halberstadt F Beby F Flueckiger M Boehnke JG Garweg 2005 Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium Graefes Arch Clin Exp Ophthalmol 243 917 925 10.1007/s00417-004-1121-6 15834606 1:CAS:528:DC%2BD2MXhtVSjtrjP (Pubitemid 41386717)
4. FA Teba A Mohr C Eckardt D Wong S Kusaka BC Joondeph EJ Feron P Stalmans K Van Overdam GR Melles 2003 Trypan blue staining in vitreoretinal surgery Ophthalmology 110 2409 2412 10.1016/S0161-6420(03)00716-4 14644726 (Pubitemid 37485173)
5. TL Jackson J Hillenkamp BC Knight JJ Zhang D Thomas MR Stanford J Marshall 2004 Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures Invest Ophthalmol Vis Sci 45 2778 2785 10.1167/iovs.04-0320 15277504 (Pubitemid 38998877)
6. A Gandorfer C Haritoglou A Gandorfer A Kampik 2003 Retinal damage from indocyanine green in experimental macular surgery Invest Ophthalmol Vis Sci 44 316 323 10.1167/iovs.02-0545 12506091 (Pubitemid 36134291)
7. T Funahashi 1980 The vital staining of the eye (author's transl) Nippon Ganka Gakkai Zasshi 84 1826 1880 6166182 1:STN:280:DyaL3M3ivFWlsg%3D%3D
8. K Li D Wong P Hiscott P Stanga C Groenewald J McGalliard 2003 Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings Br J Ophthalmol 87 216 219 10.1136/bjo.87.2.216 12543755 1:STN:280:DC%2BD3s%2FjsFyrsg%3D%3D (Pubitemid 36152751)
9. KA Rezai L Farrokh-Siar EM Gasyna JT Ernest 2004 Trypan blue induces apoptosis in human retinal pigment epithelial cells Am J Ophthalmol 138 492 495 10.1016/j.ajo.2004.03.033 15364242 1:CAS:528:DC%2BD2cXnsFWjt7s%3D (Pubitemid 39208587)
10. C Haritoglou K Eibl M Schaumberger AJ Mueller S Priglinger C Alge A Kampik 2004 Functional outcome after trypan blue-assisted vitrectomy for macular pucker: a prospective, randomized, comparative trial Am J Ophthalmol 138 1 5 10.1016/j.ajo.2004.03.005 15234276 (Pubitemid 38850243)
11. A Iriyama S Uchida Y Yanagi Y Tamaki Y Inoue K Matsuura K Kadonosono M Araie 2004 Effects of indocyanine green on retinal ganglion cells Invest Ophthalmol Vis Sci 45 943 947 10.1167/iovs.03-1026 14985315 (Pubitemid 38868396)
12. CA Gass C Haritoglou M Schaumberger A Kampik 2003 Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane Graefes Arch Clin Exp Ophthalmol 241 716 720 10.1007/s00417-003-0710-0 12920526 (Pubitemid 37265812)
13. A Uemura S Kanda Y Sakamoto H Kita 2003 Visual field defects after uneventful vitrectomy for epiretinal membrane with indocyanine green-assisted internal limiting membrane peeling Am J Ophthalmol 136 252 257 10.1016/S0002-9394(03)00157-0 12888046 (Pubitemid 36904071)
14. S Kanda A Uemura T Yamashita H Kita K Yamakiri T Sakamoto 2004 Visual field defects after intravitreous administration of indocyanine green in macular hole surgery Arch Ophthalmol 122 1447 1451 10.1001/archopht.122.10.1447 15477455 1:CAS:528:DC%2BD2cXpsVGgsLk%3D (Pubitemid 39336543)
15. J Hillenkamp P Saikia WA Herrmann C Framme VP Gabel HG Sachs 2007 Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial Graefes Arch Clin Exp Ophthalmol 245 973 979 10.1007/s00417-006-0485-1 17186261 1:CAS:528:DC%2BD2sXms1ykur0%3D
16. N Nagai S Ishida K Shinoda Y Imamura K Noda M Inoue 2007 Surgical effects and complications of indocyanine green-assisted internal limiting membrane peeling for idiopathic macular hole Acta Ophthalmol Scand 85 883 889 10.1111/j.1600-0420.2007.00973.x 17662096 (Pubitemid 350142814)
17. NE Engelbrecht J Freeman P Sternberg Jr TM Aaberg Sr TM Aaberg Jr DF Martin BD Sippy 2002 Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling Am J Ophthalmol 133 89 94 10.1016/S0002-9394(01)01293-4 11755843 (Pubitemid 34076506)
18. TL Jackson B Vote BC Knight A El-Amir MR Stanford J Marshall 2004 Safety testing of infracyanine green using retinal pigment epithelium and glial cell cultures Invest Ophthalmol Vis Sci 45 3697 3703 10.1167/iovs.04-0387 15452079 (Pubitemid 39298588)
19. C Haritoglou A Gandorfer M Schaumberger R Tadayoni A Gandorfer A Kampik 2003 Light-absorbing properties and osmolarity of indocyanine-green depending on concentration and solvent medium Invest Ophthalmol Vis Sci 44 2722 2729 10.1167/iovs.02-1283 12766079 (Pubitemid 36618436)
20. JD Gass 1995 Reappraisal of biomicroscopic classification of stages of development of a macular hole Am J Ophthalmol 119 752 759 7785690 1:STN:280:DyaK2MzgsFahtg%3D%3D
21. M la Cour J Friis 2002 Macular holes: classification, epidemiology, natural history and treatment Acta Ophthalmol Scand 80 579 587 10.1034/j.1600-0420.2002.800605.x 12485276 (Pubitemid 36024468)
22. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group 1999 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report Arch Ophthalmol 117 1329 1345
23. W Radner W Obermayer S Richter-Mueksch U Willinger M Velikay-Parel B Eisenwort 2002 The validity and reliability of short German sentences for measuring reading speed Graefes Arch Clin Exp Ophthalmol 240 461 467 10.1007/s00417-002-0443-5 12107513 (Pubitemid 36097067)
24. HL Brooks Jr 2000 Macular hole surgery with and without internal limiting membrane peeling Ophthalmology 107 1939 1948 10.1016/S0161-6420(00)00331-6 11013203 discussion 1948-1949
25. A Sivalingam RC Eagle Jr JS Duker GC Brown WE Benson WH Annesley Jr J Federman 1990 Visual prognosis correlated with the presence of internal-limiting membrane in histopathologic specimens obtained from epiretinal membrane surgery Ophthalmology 97 1549 1552 2255528 1:STN:280:DyaK3M%2FnsVGgug%3D%3D
26. RG Schumann A Gandorfer SG Priglinger A Kampik C Haritoglou 2009 Vital dyes for macular surgery: a comparative electron microscopy study of the internal limiting membrane Retina 29 669 676 10.1097/IAE.0b013e318196b1c8 19174722
27. J Hillenkamp P Saikia F Gora HG Sachs CP Lohmann J Roider W Baumler VP Gabel 2005 Macular function and morphology after peeling of idiopathic epiretinal membrane with and without the assistance of indocyanine green Br J Ophthalmol 89 437 443 10.1136/bjo.2004.051250 15774920 1:STN:280: DC%2BD2M7kt1Snuw%3D%3D (Pubitemid 40469962)
28. A Feldman J Zerbib A Glacet-Bernard P Haymann G Soubrane 2008 Clinical evaluation of the use of infracyanine green staining for internal limiting membrane peeling in epimacular membrane surgery Eur J Ophthalmol 18 972 979 18988171 1:STN:280:DC%2BD1cjitFaguw%3D%3D
29. HF Yam AK Kwok KP Chan TY Lai KY Chu DS Lam CP Pang 2003 Effect of indocyanine green and illumination on gene expression in human retinal pigment epithelial cells Invest Ophthalmol Vis Sci 44 370 377 10.1167/iovs.01-1113 12506098 (Pubitemid 36134298)
30. P Costa Ede EB Rodrigues ME Farah E Dib F Penha O Magalhaes Jr BA Furlani AA Lima Filho A de Miranda M Maia 2009 Vital dyes and light sources for chromovitrectomy: comparative assessment of osmolarity, pH, and spectrophotometry Invest Ophthalmol Vis Sci 50 385 391 10.1167/iovs.08-2285 18689696
31. ME Farah M Maia EB Rodrigues 2009 Dyes in ocular surgery: principles for use in chromovitrectomy Am J Ophthalmol 148 332 340 10.1016/j.ajo.2009.04.003 19477708
32. EB Rodrigues CH Meyer S Mennel ME Farah 2007 Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy Retina 27 958 970 10.1097/01.iae.0000253051.01194.ab 17891024 (Pubitemid 47479394)
33. M Veckeneer K van Overdam J Monzer K Kobuch W van Marle H Spekreijse J van Meurs 2001 Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes Graefes Arch Clin Exp Ophthalmol 239 698 704 10.1007/s004170100341 11688671 1:CAS:528:DC%2BD3MXos1egur0%3D
34. H Yan L Dhurjon DR Chow D Williams JC Chen 1998 Visual field defect after pars plana vitrectomy Ophthalmology 105 1612 1616 10.1016/S0161-6420(98)99026-1 9754165 1:STN:280:DyaK1cvis1OksQ%3D%3D (Pubitemid 28513508)
35. HC Boldt PM Munden JC Folk MG Mehaffey 1996 Visual field defects after macular hole surgery Am J Ophthalmol 122 371 381 8794710 1:STN:280: DyaK28zoslWksg%3D%3D
36. J Orellana RM Lieberman 1993 Stage III macular hole surgery Br J Ophthalmol 77 555 558 10.1136/bjo.77.9.555 8218050 1:STN:280: DyaK2c%2Fjt1Skug%3D%3D
37. Henrich PB, Haritoglou C, Meyer P, Ferreira PR, Schotzau A, Katamay R, Josifova T, Schneider U, Flammer J, Priglinger S (2009) Anatomical and functional outcome in brilliant blue G assisted chromovitrectomy. Acta Ophthalmol Apr 23 [Epub ahead of print]
38. S Mennel CH Meyer JC Schmidt S Kaempf G Thumann 2008 Trityl dyes patent blue V and brilliant blue G-clinical relevance and in vitro analysis of the function of the outer blood-retinal barrier Dev Ophthalmol 42 101 114 10.1159/000138988 18535384 1:CAS:528:DC%2BD1MXhslyqur8%3D
39. M Luke K Januschowski J Beutel C Luke S Grisanti S Peters GB Jaissle KU Bartz-Schmidt P Szurman 2008 Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina Graefes Arch Clin Exp Ophthalmol 246 817 822 10.1007/s00417-007-0761-8 18197412 1:CAS:528: DC%2BD1cXlsVGitL8%3D
40. H Enaida T Hisatomi Y Goto Y Hata A Ueno M Miura T Kubota T Ishibashi 2006 Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G Retina 26 623 630 10.1097/00006982-200607000-00006 16829803 (Pubitemid 44620361)
41. EB Rodrigues FM Penha ME Farah E de Paula Fiod Costa M Maia E Dib J Bottos E Freymuller B Furlani CH Meyer O Magalhaes Jr AA Lima-Filho A Safatle 2009 Preclinical investigation of the retinal biocompatibility of six novel vital dyes for chromovitrectomy Retina 29 497 510 10.1097/IAE.0b013e318196b1ad 19174713
42. D Yuen J Gonder A Proulx H Liu C Hutnik 2009 Comparison of the in vitro safety of intraocular dyes using two retinal cell lines: a focus on brilliant blue G and indocyanine green Am J Ophthalmol 147 251-259 e252
43. WE Smiddy AM Maguire WR Green RG Michels Z de la Cruz C Enger M Jaeger TA Rice 1989 Idiopathic epiretinal membranes Ultrastructural characteristics and clinicopathologic correlation. Ophthalmology 96 811 820 1:STN:280: DyaL1M3ps1agsg%3D%3D discussion 821
44. H Koizumi RF Spaide YL Fisher KB Freund JM Klancnik Jr LA Yannuzzi 2008 Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography Am J Ophthalmol 145 509 517 10.1016/j.ajo.2007.10.014 18191099